Sriram Varahan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sriram Varahan has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
- Sunil Laxman
Institute for Stem Cell Biology and Regenerative Medicine (inStem)
9 shared publications - Sandeep Krishna
National Centre for Biological Sciences
8 shared publications - Adhish S. Walvekar
Institute for Stem Cell Science and Regenerative Medicine (inStem), Bangalore, India
6 shared publications Dhrumi Shah
CSIR-Centre for Cellular and Molecular Biology
6 shared publicationsSudharsan Mathivathanan
CSIR-Centre for Cellular and Molecular Biology
6 shared publications- Vaibhhav Sinha
Simons Centre for the Study of Living Machines, National Centre for Biological Sciences-Tata Institute of Fundamental Research, Bangalore, India
6 shared publications
Latest Publications
- 16 November 2026
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
Systematic Screening of a Glycolysis-Targeting Small-Molecule Library Identifies Novel Inhibitors of Fungal Morphogenesis in Candida albicans
Fungal infections are an increasing global health concern, with Candida albicans emerging as a leading cause of mucosal and life-threatening systemic infections. C. albicans relies on yeast-to-hyphae transition, to establish systemic infections in the host. Our recent work demonstrated that glycolysis is a key regulator of hyphal differentiation in C. albicans. Leveraging this knowledge, we screened a small-molecule compound library containing glycolysis inhibitors for their ability to block fungal morphogenesis and identified multiple small molecules that robustly block hyphal differentiation without compromising overall growth. Among these, two compounds (PKM2-IN-6 and NPD10084, both originally identified as modulators of human pyruvate kinase M2 (Pkm2) activity) emerged as the most potent inhibitors of fungal morphogenesis, significantly attenuating hyphal differentiation, in multiple filamentation-inducing conditions. Comparative RNA-Seq analysis revealed significant perturbation of glycolysis following PKM2-IN-6 treatment, while molecular docking analysis predicted that these compounds bind to specific pockets of pyruvate kinase in C. albicans. Interestingly, PKM2-IN-6 treatment resulted in the repression of multiple genes associated with fungal morphogenesis, biofilm formation, and virulence. These transcriptional changes were accompanied by a significant reduction in biofilm formation and increased sensitivity to conventional antifungal drugs, including amphotericin B and fluconazole, in the presence of both compounds, PKM2-IN-6 and NPD10084. Furthermore, administration of PKM2-IN-6 significantly improved the survival of mice in a murine model of systemic candidiasis underscoring the in vivo efficacy of this compound. Collectively, our study has identified novel small molecules that target fungal morphogenesis and virulence in C. albicans, establishing inhibition of glycolysis as a promising antifungal strategy.
- 16 November 2026
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
Systematic Screening of a Glycolysis-Targeting Small-Molecule Library Identifies Novel Inhibitors of Fungal Morphogenesis in Candida albicans
Fungal infections are an increasing global health concern, with Candida albicans emerging as a leading cause of mucosal and life-threatening systemic infections. C. albicans relies on yeast-to-hyphae transition, to establish systemic infections in the host. Our recent work demonstrated that glycolysis is a key regulator of hyphal differentiation in C. albicans. Leveraging this knowledge, we screened a small-molecule compound library containing glycolysis inhibitors for their ability to block fungal morphogenesis and identified multiple small molecules that robustly block hyphal differentiation without compromising overall growth. Among these, two compounds (PKM2-IN-6 and NPD10084, both originally identified as modulators of human pyruvate kinase M2 (Pkm2) activity) emerged as the most potent inhibitors of fungal morphogenesis, significantly attenuating hyphal differentiation, in multiple filamentation-inducing conditions. Comparative RNA-Seq analysis revealed significant perturbation of glycolysis following PKM2-IN-6 treatment, while molecular docking analysis predicted that these compounds bind to specific pockets of pyruvate kinase in C. albicans. Interestingly, PKM2-IN-6 treatment resulted in the repression of multiple genes associated with fungal morphogenesis, biofilm formation, and virulence. These transcriptional changes were accompanied by a significant reduction in biofilm formation and increased sensitivity to conventional antifungal drugs, including amphotericin B and fluconazole, in the presence of both compounds, PKM2-IN-6 and NPD10084. Furthermore, administration of PKM2-IN-6 significantly improved the survival of mice in a murine model of systemic candidiasis underscoring the in vivo efficacy of this compound. Collectively, our study has identified novel small molecules that target fungal morphogenesis and virulence in C. albicans, establishing inhibition of glycolysis as a promising antifungal strategy.
- 21 October 2026
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 12 (11) , 3569-3570
Call for Papers: Early Career Researchers in Infectious Diseases
- 21 October 2026
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 12 (11) , 3569-3570
Call for Papers: Early Career Researchers in Infectious Diseases
- 21 August 2026
- Published by Oxford University Press (OUP) in Genetics
- Vol. 234 (2)
A glycolysis–calcineurin regulatory axis orchestrates titan cell formation in Cryptococcus neoformans
Cryptococcus neoformans is an opportunistic fungal pathogen that causes pulmonary infections and life-threatening meningoencephalitis in immunocompromised individuals. In addition to the polysaccharide capsule and melanin, titan cell formation is a key virulence trait that promotes immune evasion and disease progression. Despite the established role of titan cells in C. neoformans pathogenesis, the molecular mechanisms governing their formation remain poorly understood. Here, we demonstrate that glycolysis is critical for titan cell formation in C. neoformans. Pharmacological inhibition or genetic disruption of glycolysis significantly impaired titanization, whereas exogenous cAMP add-back restored the defect. To elucidate the underlying mechanism, we performed comparative RNA-seq analyses of wild-type, hxk2Δ, and hxk2Δ supplemented with cAMP under titan cell-inducing conditions. Transcriptomic analyses revealed significant downregulation of a large subset of calcineurin-responsive genes in the hxk2Δ mutant, many of which were restored upon cAMP supplementation. Consistent with these findings, pharmacological inhibition of calcineurin using FK506 or cyclosporin A markedly reduced titan cell formation, establishing an essential role for calcineurin signaling in this morphological transition. Furthermore, supplementation with CaCl2 rescued the titanization defect of the hxk2Δ mutant, whereas chelation of extracellular calcium with EGTA significantly inhibited titanization in wild-type cells. Using calcium-sensitive dyes, we found that intracellular calcium levels were substantially reduced in the hxk2Δ mutant and were restored by CaCl2 or cAMP supplementation. Collectively, our findings uncover a previously unrecognized glycolysis–calcineurin regulatory axis that governs titan cell formation and establishes a direct mechanistic link between central carbon metabolism, calcium homeostasis, and fungal morphogenesis.
- 21 August 2026
- Published by Oxford University Press (OUP) in Genetics
- Vol. 234 (2)
A glycolysis–calcineurin regulatory axis orchestrates titan cell formation in Cryptococcus neoformans
Cryptococcus neoformans is an opportunistic fungal pathogen that causes pulmonary infections and life-threatening meningoencephalitis in immunocompromised individuals. In addition to the polysaccharide capsule and melanin, titan cell formation is a key virulence trait that promotes immune evasion and disease progression. Despite the established role of titan cells in C. neoformans pathogenesis, the molecular mechanisms governing their formation remain poorly understood. Here, we demonstrate that glycolysis is critical for titan cell formation in C. neoformans. Pharmacological inhibition or genetic disruption of glycolysis significantly impaired titanization, whereas exogenous cAMP add-back restored the defect. To elucidate the underlying mechanism, we performed comparative RNA-seq analyses of wild-type, hxk2Δ, and hxk2Δ supplemented with cAMP under titan cell-inducing conditions. Transcriptomic analyses revealed significant downregulation of a large subset of calcineurin-responsive genes in the hxk2Δ mutant, many of which were restored upon cAMP supplementation. Consistent with these findings, pharmacological inhibition of calcineurin using FK506 or cyclosporin A markedly reduced titan cell formation, establishing an essential role for calcineurin signaling in this morphological transition. Furthermore, supplementation with CaCl2 rescued the titanization defect of the hxk2Δ mutant, whereas chelation of extracellular calcium with EGTA significantly inhibited titanization in wild-type cells. Using calcium-sensitive dyes, we found that intracellular calcium levels were substantially reduced in the hxk2Δ mutant and were restored by CaCl2 or cAMP supplementation. Collectively, our findings uncover a previously unrecognized glycolysis–calcineurin regulatory axis that governs titan cell formation and establishes a direct mechanistic link between central carbon metabolism, calcium homeostasis, and fungal morphogenesis.
- Open Access
Systematic Screening of a Glycolysis-targeting Small-molecule Library Identifies Novel Inhibitors of Fungal Morphogenesis in Candida albicans
Fungal infections are an increasing global health concern, with Candida albicans emerging as a leading cause of mucosal and life-threatening systemic infections. C. albicans relies on yeast-to-hyphae transition, to establish systemic infections in the host. Our recent work demonstrated that glycolysis is a key regulator of hyphal differentiation in C. albicans (Shah et al., 2025). Leveraging this knowledge, we screened a small-molecule compound library containing glycolysis inhibitors for their ability to block fungal morphogenesis. Our systematic screen of glycolysis-targeting compounds acting on distinct enzymatic steps of glycolysis identified multiple inhibitors of glycolysis that robustly block hyphal differentiation in C. albicans without compromising its overall growth. While early glycolysis pathway inhibitors showed moderate effects, two compounds (NPD10084 and PKM2-IN-6) targeting pyruvate kinase activity emerged as the most potent inhibitors of fungal morphogenesis, completely blocking hyphal differentiation in C. albicans , in multiple filamentation-inducing conditions. Notably, these inhibitors effectively impaired biofilm formation and exhibited synergistic activity with conventional antifungal drugs, including amphotericin B and fluconazole. Furthermore, administration of NPD10084 and PKM2-IN-6 significantly improved the survival of mice in a systemic model of murine candidiasis underscoring the in vivo efficacy of these compounds. Molecular docking analysis showed stable binding of both compounds to the ATP-binding pocket of pyruvate kinase, suggesting ATP-competitive inhibition. Collectively, our study has identified novel inhibitors of fungal morphogenesis in C. albicans that target pyruvate kinase activity to block a key virulence strategy of this human fungal pathogen.
Open AccessSystematic Screening of a Glycolysis-targeting Small-molecule Library Identifies Novel Inhibitors of Fungal Morphogenesis in Candida albicans
Fungal infections are an increasing global health concern, with Candida albicans emerging as a leading cause of mucosal and life-threatening systemic infections. C. albicans relies on yeast-to-hyphae transition, to establish systemic infections in the host. Our recent work demonstrated that glycolysis is a key regulator of hyphal differentiation in C. albicans (Shah et al., 2025). Leveraging this knowledge, we screened a small-molecule compound library containing glycolysis inhibitors for their ability to block fungal morphogenesis. Our systematic screen of glycolysis-targeting compounds acting on distinct enzymatic steps of glycolysis identified multiple inhibitors of glycolysis that robustly block hyphal differentiation in C. albicans without compromising its overall growth. While early glycolysis pathway inhibitors showed moderate effects, two compounds (NPD10084 and PKM2-IN-6) targeting pyruvate kinase activity emerged as the most potent inhibitors of fungal morphogenesis, completely blocking hyphal differentiation in C. albicans , in multiple filamentation-inducing conditions. Notably, these inhibitors effectively impaired biofilm formation and exhibited synergistic activity with conventional antifungal drugs, including amphotericin B and fluconazole. Furthermore, administration of NPD10084 and PKM2-IN-6 significantly improved the survival of mice in a systemic model of murine candidiasis underscoring the in vivo efficacy of these compounds. Molecular docking analysis showed stable binding of both compounds to the ATP-binding pocket of pyruvate kinase, suggesting ATP-competitive inhibition. Collectively, our study has identified novel inhibitors of fungal morphogenesis in C. albicans that target pyruvate kinase activity to block a key virulence strategy of this human fungal pathogen.
- Open Access
- 6 February 2026
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 14
Glycolysis-dependent sulfur metabolism orchestrates morphological plasticity and virulence in fungi
Fungi exhibit remarkable morphological plasticity, which allows them to undergo reversible transitions between distinct cellular states in response to changes in their environment. This phenomenon, termed fungal morphogenesis, is critical for fungi to survive and colonize diverse ecological niches and establish infections in a variety of hosts. Despite significant advancements in the field with respect to understanding the gene regulatory networks that control these transitions, the metabolic determinants of fungal morphogenesis remain poorly characterized. In this study, we uncover a previously uncharacterized, conserved dependency between central carbon metabolism and de novo biosynthesis of sulfur-containing amino acids that is critical for fungal morphogenesis in two key fungal species. Using a multidisciplinary approach, we demonstrate that glycolytic flux is crucial to drive fungal morphogenesis in a cAMP-independent manner and perturbation of this pathway leads to a significant downregulation in the expression of genes involved in de novo biosynthesis of sulfur-containing amino acids. Remarkably, exogenous supplementation of sulfur-containing amino acids robustly rescues the morphogenesis defect induced by the perturbation of glycolysis in both Saccharomyces cerevisiae and Candida albicans , underscoring the pivotal role of de novo biosynthesis of sulfur-containing amino acids as a downstream effector of morphogenesis. Furthermore, a C. albicans mutant lacking the glycolytic enzyme, phosphofructokinase-1 (Pfk1), exhibited significantly reduced survival within murine macrophages and attenuated virulence in a murine model of systemic candidiasis. Overall, our work elucidates a previously uncharacterized coupling between glycolysis and sulfur metabolism that is critical for driving fungal morphogenesis, contributing to our understanding of this conserved phenomenon.
- 6 February 2026
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 14
Open AccessGlycolysis-dependent sulfur metabolism orchestrates morphological plasticity and virulence in fungi
Fungi exhibit remarkable morphological plasticity, which allows them to undergo reversible transitions between distinct cellular states in response to changes in their environment. This phenomenon, termed fungal morphogenesis, is critical for fungi to survive and colonize diverse ecological niches and establish infections in a variety of hosts. Despite significant advancements in the field with respect to understanding the gene regulatory networks that control these transitions, the metabolic determinants of fungal morphogenesis remain poorly characterized. In this study, we uncover a previously uncharacterized, conserved dependency between central carbon metabolism and de novo biosynthesis of sulfur-containing amino acids that is critical for fungal morphogenesis in two key fungal species. Using a multidisciplinary approach, we demonstrate that glycolytic flux is crucial to drive fungal morphogenesis in a cAMP-independent manner and perturbation of this pathway leads to a significant downregulation in the expression of genes involved in de novo biosynthesis of sulfur-containing amino acids. Remarkably, exogenous supplementation of sulfur-containing amino acids robustly rescues the morphogenesis defect induced by the perturbation of glycolysis in both Saccharomyces cerevisiae and Candida albicans , underscoring the pivotal role of de novo biosynthesis of sulfur-containing amino acids as a downstream effector of morphogenesis. Furthermore, a C. albicans mutant lacking the glycolytic enzyme, phosphofructokinase-1 (Pfk1), exhibited significantly reduced survival within murine macrophages and attenuated virulence in a murine model of systemic candidiasis. Overall, our work elucidates a previously uncharacterized coupling between glycolysis and sulfur metabolism that is critical for driving fungal morphogenesis, contributing to our understanding of this conserved phenomenon.
- Open Access
- 16 January 2026
- Published by eLife Sciences Publications, Ltd in eLife preprints
Glycolysis-dependent Sulfur Metabolism Orchestrates Morphological Plasticity and Virulence in Fungi
Fungi exhibit remarkable morphological plasticity, which allows them to undergo reversible transitions between distinct cellular states in response to changes in their environment. This phenomenon, termed fungal morphogenesis, is critical for fungi to survive and colonize diverse ecological niches and establish infections in a variety of hosts. Despite significant advancements in the field with respect to understanding the gene regulatory networks that control these transitions, the metabolic determinants of fungal morphogenesis remain poorly characterized. In this study, we uncover a previously uncharacterized, conserved dependency between central carbon metabolism and de novo biosynthesis of sulfur-containing amino acids that is critical for fungal morphogenesis, in two key fungal species. Using a multidisciplinary approach, we demonstrate that glycolytic flux is crucial to drive fungal morphogenesis in a cAMP-independent manner and perturbation of this pathway leads to a significant downregulation in the expression of genes involved in de novo biosynthesis of sulfur-containing amino acids. Remarkably, exogenous supplementation of sulfur-containing amino acids robustly rescues the morphogenesis defect induced by the perturbation of glycolysis in both Saccharomyces cerevisiae and Candida albicans, underscoring the pivotal role of de novo biosynthesis of sulfur-containing amino acid as a downstream effector of morphogenesis. Furthermore, a C. albicans mutant lacking the glycolytic enzyme, phosphofructokinase-1 (Pfk1) exhibited significantly reduced survival within murine macrophages and attenuated virulence in a murine model of systemic candidiasis. Overall, our work elucidates a previously uncharacterized coupling between glycolysis and sulfur metabolism that is critical for driving fungal morphogenesis, contributing to our understanding of this conserved phenomenon.
- 16 January 2026
- Published by eLife Sciences Publications, Ltd in eLife preprints
Open AccessGlycolysis-dependent Sulfur Metabolism Orchestrates Morphological Plasticity and Virulence in Fungi
Fungi exhibit remarkable morphological plasticity, which allows them to undergo reversible transitions between distinct cellular states in response to changes in their environment. This phenomenon, termed fungal morphogenesis, is critical for fungi to survive and colonize diverse ecological niches and establish infections in a variety of hosts. Despite significant advancements in the field with respect to understanding the gene regulatory networks that control these transitions, the metabolic determinants of fungal morphogenesis remain poorly characterized. In this study, we uncover a previously uncharacterized, conserved dependency between central carbon metabolism and de novo biosynthesis of sulfur-containing amino acids that is critical for fungal morphogenesis, in two key fungal species. Using a multidisciplinary approach, we demonstrate that glycolytic flux is crucial to drive fungal morphogenesis in a cAMP-independent manner and perturbation of this pathway leads to a significant downregulation in the expression of genes involved in de novo biosynthesis of sulfur-containing amino acids. Remarkably, exogenous supplementation of sulfur-containing amino acids robustly rescues the morphogenesis defect induced by the perturbation of glycolysis in both Saccharomyces cerevisiae and Candida albicans, underscoring the pivotal role of de novo biosynthesis of sulfur-containing amino acid as a downstream effector of morphogenesis. Furthermore, a C. albicans mutant lacking the glycolytic enzyme, phosphofructokinase-1 (Pfk1) exhibited significantly reduced survival within murine macrophages and attenuated virulence in a murine model of systemic candidiasis. Overall, our work elucidates a previously uncharacterized coupling between glycolysis and sulfur metabolism that is critical for driving fungal morphogenesis, contributing to our understanding of this conserved phenomenon.
- 11 August 2025
- Published by Elsevier in Journal of Molecular Biology
- Vol. 437 (21) , 169387
Chats and Spats of Autophagy and Innate Immune Systems
- 11 August 2025
- Published by Elsevier in Journal of Molecular Biology
- Vol. 437 (21) , 169387
Chats and Spats of Autophagy and Innate Immune Systems
- Open Access
Glycolysis-dependent Sulfur Metabolism Orchestrates Morphological Plasticity and Virulence in Fungi
Fungi exhibit remarkable morphological plasticity, which allows them to undergo reversible transitions between distinct cellular states in response to changes in their environment. This phenomenon, termed fungal morphogenesis, is critical for fungi to survive and colonize diverse ecological niches and establish infections in a variety of hosts. Despite significant advancements in the field with respect to understanding the gene regulatory networks that control these transitions, the metabolic determinants of fungal morphogenesis remain poorly characterized. In this study, we uncover a previously uncharacterized, conserved dependency between central carbon metabolism and de novo biosynthesis of sulfur-containing amino acids that is critical for fungal morphogenesis, in two key fungal species. Using a multidisciplinary approach, we demonstrate that glycolytic flux is crucial to drive fungal morphogenesis in a cAMP-independent manner and perturbation of this pathway leads to a significant downregulation in the expression of genes involved in de novo biosynthesis of sulfur-containing amino acids. Remarkably, exogenous supplementation of sulfur-containing amino acids robustly rescues the morphogenesis defect induced by the perturbation of glycolysis in both Saccharomyces cerevisiae and Candida albicans , underscoring the pivotal role of de novo biosynthesis of sulfur-containing amino acid as a downstream effector of morphogenesis. Furthermore, a C. albicans mutant lacking the glycolytic enzyme, phosphofructokinase-1 (Pfk1) exhibited significantly reduced survival within murine macrophages and attenuated virulence in a murine model of systemic candidiasis. Overall, our work elucidates a previously uncharacterized coupling between glycolysis and sulfur metabolism that is critical for driving fungal morphogenesis, contributing to our understanding of this conserved phenomenon.
Open AccessGlycolysis-dependent Sulfur Metabolism Orchestrates Morphological Plasticity and Virulence in Fungi
Fungi exhibit remarkable morphological plasticity, which allows them to undergo reversible transitions between distinct cellular states in response to changes in their environment. This phenomenon, termed fungal morphogenesis, is critical for fungi to survive and colonize diverse ecological niches and establish infections in a variety of hosts. Despite significant advancements in the field with respect to understanding the gene regulatory networks that control these transitions, the metabolic determinants of fungal morphogenesis remain poorly characterized. In this study, we uncover a previously uncharacterized, conserved dependency between central carbon metabolism and de novo biosynthesis of sulfur-containing amino acids that is critical for fungal morphogenesis, in two key fungal species. Using a multidisciplinary approach, we demonstrate that glycolytic flux is crucial to drive fungal morphogenesis in a cAMP-independent manner and perturbation of this pathway leads to a significant downregulation in the expression of genes involved in de novo biosynthesis of sulfur-containing amino acids. Remarkably, exogenous supplementation of sulfur-containing amino acids robustly rescues the morphogenesis defect induced by the perturbation of glycolysis in both Saccharomyces cerevisiae and Candida albicans , underscoring the pivotal role of de novo biosynthesis of sulfur-containing amino acid as a downstream effector of morphogenesis. Furthermore, a C. albicans mutant lacking the glycolytic enzyme, phosphofructokinase-1 (Pfk1) exhibited significantly reduced survival within murine macrophages and attenuated virulence in a murine model of systemic candidiasis. Overall, our work elucidates a previously uncharacterized coupling between glycolysis and sulfur metabolism that is critical for driving fungal morphogenesis, contributing to our understanding of this conserved phenomenon.
- Open Access
- 29 August 2024
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 12
The deubiquitinase Ubp3/Usp10 constrains glucose-mediated mitochondrial repression via phosphate budgeting
Many cells in high glucose repress mitochondrial respiration, as observed in the Crabtree and Warburg effects. Our understanding of biochemical constraints for mitochondrial activation is limited. Using a Saccharomyces cerevisiae screen, we identified the conserved deubiquitinase Ubp3 (Usp10), as necessary for mitochondrial repression. Ubp3 mutants have increased mitochondrial activity despite abundant glucose, along with decreased glycolytic enzymes, and a rewired glucose metabolic network with increased trehalose production. Utilizing Δubp3 cells, along with orthogonal approaches, we establish that the high glycolytic flux in glucose continuously consumes free Pi. This restricts mitochondrial access to inorganic phosphate (Pi), and prevents mitochondrial activation. Contrastingly, rewired glucose metabolism with enhanced trehalose production and reduced GAPDH (as in Δubp3 cells) restores Pi. This collectively results in increased mitochondrial Pi and derepression, while restricting mitochondrial Pi transport prevents activation. We therefore suggest that glycolytic-flux dependent intracellular Pi budgeting is a key constraint for mitochondrial repression.
- 29 August 2024
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 12
Open AccessThe deubiquitinase Ubp3/Usp10 constrains glucose-mediated mitochondrial repression via phosphate budgeting
Many cells in high glucose repress mitochondrial respiration, as observed in the Crabtree and Warburg effects. Our understanding of biochemical constraints for mitochondrial activation is limited. Using a Saccharomyces cerevisiae screen, we identified the conserved deubiquitinase Ubp3 (Usp10), as necessary for mitochondrial repression. Ubp3 mutants have increased mitochondrial activity despite abundant glucose, along with decreased glycolytic enzymes, and a rewired glucose metabolic network with increased trehalose production. Utilizing Δubp3 cells, along with orthogonal approaches, we establish that the high glycolytic flux in glucose continuously consumes free Pi. This restricts mitochondrial access to inorganic phosphate (Pi), and prevents mitochondrial activation. Contrastingly, rewired glucose metabolism with enhanced trehalose production and reduced GAPDH (as in Δubp3 cells) restores Pi. This collectively results in increased mitochondrial Pi and derepression, while restricting mitochondrial Pi transport prevents activation. We therefore suggest that glycolytic-flux dependent intracellular Pi budgeting is a key constraint for mitochondrial repression.
- 17 May 2024
- Published by Elsevier in Trends in Microbiology
- Vol. 32 (9) , 925-926
Enterococcus faecalis
- 17 May 2024
- Published by Elsevier in Trends in Microbiology
- Vol. 32 (9) , 925-926
Enterococcus faecalis